| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/18/1999 | CA2297736A1 Treatment of acute lung injury and fibrosis with antagonists of .alpha.v.beta.6 |
| 02/18/1999 | CA2297382A1 Recombinant expression of insulin c-peptide |
| 02/18/1999 | CA2296525A1 Materials and methods for controlling homopteran pests |
| 02/18/1999 | CA2288895A1 Genetically engineered duckweed |
| 02/18/1999 | CA2274302A1 Lsr receptor, activity, cloning, and uses for diagnosing, preventing and/or treating obesity and related risks or complications |
| 02/18/1999 | CA2268737A1 Replication-competent recombinant sabin type 1 strain of poliovirus |
| 02/17/1999 | EP0897114A2 A method of identifying agonist and antagonists for tumor necrosis related receptors TR1 and TR2 |
| 02/17/1999 | EP0897013A1 Method for transforming indica rice |
| 02/17/1999 | EP0897011A2 Novel arginine deiminase |
| 02/17/1999 | EP0897004A2 Histidyl tRNA synthetase from Streptococcus pneumoniae (hisS) |
| 02/17/1999 | EP0897001A1 Polypeptide having a GTPase regulator activity, nucleic acids coding therefore and their use in diagnostics and therapy |
| 02/17/1999 | EP0896626A1 Monoclonal antibody to cea, conjugates comprising said antibody, and their therapeutic use in an adept system |
| 02/17/1999 | EP0896625A2 Recombinant ribonuclease proteins |
| 02/17/1999 | EP0896622A1 Chemokine alpha 2 |
| 02/17/1999 | EP0896620A1 Modified nuclear glucocorticoid receptor, fusion protein, and dna fragments coding for said receptor and said fusion protein |
| 02/17/1999 | EP0896586A1 ErbB3 ANTIBODIES |
| 02/17/1999 | EP0896548A1 Apparatus for the large scale growth and packaging of cell suspensions and three-dimensional tissue cultures |
| 02/17/1999 | EP0896506A1 Methods for inducing immune responsiveness in a subject |
| 02/17/1999 | CN1208438A Transport proteins and their uses |
| 02/17/1999 | CN1208420A Antisecretory factor peptides regulating pathological permeability changes |
| 02/17/1999 | CN1208078A Genes encoding branched-chain alpha-ketoacid dehydrogense complex from streptomyces Avermitilis |
| 02/16/1999 | US5872234 Antitumor |
| 02/16/1999 | US5872226 Fibroblast growth factor homologous factor-1 (FHF-1) |
| 02/16/1999 | US5872218 Monoclonal antibodies |
| 02/16/1999 | US5872212 Pesticidal proteins and strains |
| 02/16/1999 | US5872209 Artificial recombinant substrate (rAGG 1) and native aggrecan to determine the proteolytic activity of `aggrecanase` in cell culture systems |
| 02/16/1999 | US5872012 Protamine-reactive IGM antibodies |
| 02/16/1999 | US5872005 Packaging cell lines for adeno-associated viral vectors |
| 02/16/1999 | US5871999 Cell culture process and medium for the growth of adherent animal cells |
| 02/16/1999 | US5871998 Gene expression in transformed eukaryotic host cell; genetic engineering |
| 02/16/1999 | US5871997 A gene therapy treating with a glycolytic enzyme |
| 02/16/1999 | US5871996 First agent comprising isolated virus having reverse transcriptase activity, second agent distinct from first, comprising nucleotides; both agents associated with multiple sclerosis and purifiable from viral isolate pol-2 and ms7pg |
| 02/16/1999 | US5871985 Vehicles containing cells for implanting in the tissue of an individual are prepared having cells dispersed in a particulate, essentially non cross-linked chitosan core matrix that is enclosed within a semipermeable membrane |
| 02/16/1999 | US5871984 Compounds and methods for site directed mutations in eukaryotic cells |
| 02/16/1999 | US5871982 Hybrid vectors and genes |
| 02/16/1999 | US5871973 Cell division regulators |
| 02/16/1999 | US5871970 Calcium-binding protein |
| 02/16/1999 | US5871967 Cloning of a novel G-Protein coupled 7TM receptor |
| 02/16/1999 | US5871904 Immunassay of non-A, non-B hepatitis virus-related antigens, monoclonal antibodies for use therein, and hybridomas producing the antibodies |
| 02/16/1999 | US5871767 Implanting in patient immunoisolatory vehicle comprising core containing living cells which secrete biologically active material dispersed in biocompatible matrix, surrounded by biocompatible external jacket |
| 02/16/1999 | US5871753 A compound comprising two or more multimerized ligands each independently selected from the group consisting of fk506, fk520 and cyclosporin, or macrocyclic derivatives thereof. |
| 02/16/1999 | US5871745 Isolated virus having reverse transcriptase activity, second agent distinct from first, comprising nucleotides; both agents associated with multiple sclerosis and purifiable from viral isolate pol-2 and ms7pg |
| 02/16/1999 | US5871744 Method for generating birnavirus from synthetic RNA transcripts |
| 02/16/1999 | US5871735 Isoferritin as a marker for pathological pregnancy |
| 02/16/1999 | US5871732 Dna sequences and genetic engineering for aids |
| 02/16/1999 | US5871728 Enhancing tolerogenicity in host mammal to transplant graft specimen from donor; propagation in cytokine prior to administering |
| 02/16/1999 | US5871725 In the absence of alone or in combination with interleukin-two; anticarcinogenic agents |
| 02/16/1999 | US5871472 To preselected brain areas |
| 02/16/1999 | CA2000913C Family of high affinity antibodies for cancer treatment |
| 02/16/1999 | CA1340397C Method of preparation and use for zona pellucida antigens and antibodies for sterilization and contraception |
| 02/16/1999 | CA1340391C Monoclonal antibodies against atrial, natriuretic peptides of humans |
| 02/15/1999 | CA2224096A1 The g-protein coupled receptor hfia041 |
| 02/14/1999 | CA2213089A1 Method of encapsulating living cellular material in an artifical matrix for culture or regeneration |
| 02/13/1999 | CA2240637A1 Novel ratb |
| 02/13/1999 | CA2240623A1 Novel rata |
| 02/13/1999 | CA2234415A1 A method of identifying agonist and antagonists for tumor necrosis related receptors tr1 and tr2 |
| 02/12/1999 | CA2239835A1 Human sdr2 cdna clone |
| 02/11/1999 | WO1999006840A1 Collagen-peptide assay method |
| 02/11/1999 | WO1999006597A1 Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening |
| 02/11/1999 | WO1999006581A1 Transgenic plants using the tdc gene for crop improvement |
| 02/11/1999 | WO1999006580A2 Stress tolerance and delayed senescence in plants |
| 02/11/1999 | WO1999006578A2 Genetic method for controlling sprouting |
| 02/11/1999 | WO1999006575A1 Starch debranching enzymes |
| 02/11/1999 | WO1999006573A1 New beta-glucanase from a bacillus |
| 02/11/1999 | WO1999006572A1 Synaptojanin isoform |
| 02/11/1999 | WO1999006568A1 Bacillus thuringiensis cry6-toxins with improved activity |
| 02/11/1999 | WO1999006564A1 Expression of antimicrobial peptide genes in plants, and their use in creating resistance to multiple plant pathogens |
| 02/11/1999 | WO1999006563A1 Novel bone mineralization proteins, dna, vectors, expression systems |
| 02/11/1999 | WO1999006558A1 Human longevity-assurance protein homologs |
| 02/11/1999 | WO1999006557A2 Mammalian cell membrane proteins; related reagents |
| 02/11/1999 | WO1999006539A1 Zggbp1, novel peptides related to bipolar affective disorder type 1, sequences and uses thereof |
| 02/11/1999 | WO1999006535A1 Screening assays for g protein coupled receptor agonists and antagonists |
| 02/11/1999 | WO1999006534A1 Production of avian embryonic germ (eg) cell lines by prolonged culturing of pgcs, use thereof for cloning and chimerization |
| 02/11/1999 | WO1999006533A1 Avian primordial germ cell (pgc) cell line and a method for long term culturing thereof |
| 02/11/1999 | WO1999006442A1 EPO PRIMARY RESPONSE GENE, EPRG3Spt |
| 02/11/1999 | WO1999006439A2 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN ENDODERM |
| 02/11/1999 | WO1999006428A1 Tango-72 and tango-77 nucleic acid molecules and polypeptides |
| 02/11/1999 | WO1999006427A1 Tango-78, tango-79, and tango-81 nucleic acid molecules and polypeptides |
| 02/11/1999 | WO1999006426A1 Novel molecules of the tango-77 related protein family and uses thereof |
| 02/11/1999 | WO1999006423A1 83 human secreted proteins |
| 02/11/1999 | WO1999006068A2 Recombinant dimeric envelope vaccine against flaviviral infection |
| 02/11/1999 | WO1999006066A2 Catalytic monoclonal antibodies with protease activity for the selective lysis of the protein component of plaques and aggregates related to pathological conditions |
| 02/11/1999 | WO1999006064A1 Method for preventing and treating hearing loss using a neurturin protein product |
| 02/11/1999 | WO1999006063A1 EPO PRIMARY RESPONSE GENE, EPRG3pt |
| 02/11/1999 | WO1999006059A2 Methods and compositions relating to no-mediated cytotoxicity |
| 02/11/1999 | WO1998051812A3 Polyhydroxyalkanoates for in vivo applications |
| 02/11/1999 | DE19734218A1 Verfahren zur Ertragssteigerung in Pflanzen Method for increasing yield in plants |
| 02/11/1999 | CA2633155A1 Stress tolerance and delayed senescence in plants |
| 02/11/1999 | CA2493240A1 Methods for detecting or assaying virus |
| 02/11/1999 | CA2300380A1 Avian primordial germ cell (pgc) cell line and a method for long term culturing thereof |
| 02/11/1999 | CA2300336A1 Production of avian embryonic germ (eg) cell lines by prolonged culturing of pgcs, use thereof for cloning and chimerization |
| 02/11/1999 | CA2299615A1 Expression of antimicrobial peptide genes in plants, and their use in creating resistance to multiple plant pathogens |
| 02/11/1999 | CA2299276A1 Tango-78, tango-79, and tango-81 nucleic acid molecules and polypeptides |
| 02/11/1999 | CA2299256A1 Tango-72 and tango-77 nucleic acid molecules and polypeptides |
| 02/11/1999 | CA2299055A1 Novel molecules of the tango-77 related protein family and uses thereof |
| 02/11/1999 | CA2298882A1 Transgenic plants using the tdc gene for crop improvement |
| 02/11/1999 | CA2298852A1 83 human secreted proteins |
| 02/11/1999 | CA2298766A1 Human longevity-assurance protein homologs |
| 02/11/1999 | CA2298573A1 Synaptojanin isoform |
| 02/11/1999 | CA2298538A1 Recombinant dimeric envelope vaccine against flaviviral infection |